Heavy Menstrual Bleeding: Clinical Trials

57 trials for Heavy Menstrual Bleeding, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 13 unknown, 5 recruiting, 4 terminated. 17 Phase 3, 14 Not applicable, 9 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 14, Unknown 2, Recruiting 1
Not applicable14Completed 7, Unknown 4, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 49Unknown 5, Completed 3, Terminated 1
Phase 11Withdrawn 1
Phase 21Completed 1

Follow Heavy Menstrual Bleeding: new trials by email Literature Review of Heavy Menstrual Bleeding trials Research Report on Heavy Menstrual Bleeding

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Heavy Menstrual Bleeding and Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University
Dysmenorrhea, Heavy Menstrual Bleeding
Not yet recruitingAssiut University4862026-10-012026-10-01
Delivering tAN to Reduce HMB: The LUNA Study
Sparrow Link, Sparrow Link (Sham) - Heavy Menstrual Bleeding
Not applicableRecruitingSpark Biomedical, Inc.802026-03-062026-10-20
Effectiveness of an mHealth Innovation on the Impact of Menstrual Complaints in Adolescents
Menstrual Tracker and Education Application - Dysmenorrhea, Heavy Menstrual Bleeding
Not applicableNot yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)8742026-02-162026-03-09
Evaluating the Reliability and Validity of the Arabic Version of the SAMANTA Questionnaire: A Step Toward Improved Diagnosis of Heavy Menstrual Bleeding
Heavy Menstrual Bleeding
Not yet recruitingAssiut University1202025-12-012025-12-05
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Levonorgestrel Intrauterine System, Norethindrone Acetate - Heavy Menstrual Bleeding, Bleeding Disorder
RecruitingOregon Health and Science University3002025-09-242025-12-17
Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial
Volta System - Heavy Menstrual Bleeding
Not applicableCompletedSpark Biomedical, Inc.402025-02-142025-09-26
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Juveena Hydrogel System - Heavy Menstrual Bleeding
Not applicableCompletedRejoni Inc.132025-02-012026-08-06
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
Heavy Menstrual Bleeding, Bleeding Disorder
RecruitingUniversity Hospital, Geneva1632024-12-172026-05-12
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses
Phase 4UnknownUniversity Health Network, Toronto202024-06-012024-06-12
Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Hypermobile Ehlers-Danlos Syndrome, Heavy Menstrual Bleeding
TerminatedSt. Jude Children's Research Hospital152024-05-102026-01-28
Heavy Menstrual Bleeding and Iron Deficiency Anemia
CBC and serum ferritin - Heavy Menstrual Bleeding
UnknownAssiut University3002024-05-012023-02-08
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Relugolix, Relugolix placebo - Heavy Menstrual Bleeding, Uterine Fibroids
Phase 3RecruitingQilu Pharmaceutical Co., Ltd.1202024-01-152026-02-02
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease
Volta System - Von Willebrand Disease, Type 1, Heavy Menstrual Bleeding
Not applicableCompletedFive Liters, Inc.292023-10-272025-04-27
A Registry to Gather Real World Use Data on the CereneĀ® Cryotherapy Device
Cerene - Heavy Menstrual Bleeding, Abnormal Uterine Bleeding
RecruitingChannel Medsystems3002023-06-092026-06-22
Menstrual Complaints in Adolescents and Adults
Menstruatie Educatie Kalender (Menstrution Education Calendar) application (MEK-app), Questionnaires - Dysmenorrhea, Heavy Menstrual Bleeding
Active not recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)20002023-05-112025-04-10
Impact of Incomplete Endometrial Ablation
hysteroscopy - Heavy Menstrual Bleeding
Active not recruitingMaxima Medical Center1212023-03-012025-06-12
IUB SEAD RED (Revolutionary Endometrial Ablation Device Study)
IUB SEAD - Heavy Menstrual Bleeding
Not applicableUnknownOcon Medical Ltd.102023-02-232023-11-09
Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.
BG2109, Placebo for BG2109, Placebo for add-back therapy - Uterine Fibroids, Heavy Menstrual Bleeding
Phase 3UnknownBio Genuine (Shanghai) Biotech Co., Ltd.3122022-12-162023-03-21
A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment
Heavy Menstrual Bleeding
CompletedBayer999992021-11-302023-07-27
A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
Heavy Menstrual Bleeding, Uterine Fibroids
TerminatedAbbVie232021-10-052023-08-14

Showing 20 of 57. Sign in to see all of them.

Narrower conditions

Menorrhagia (57)  ·  Leiomyoma (15)  ·  Dysmenorrhea (4)  ·  Hemostatic Disorders (4)  ·  Anemia, Iron-Deficiency (3)  ·  Hemorrhage (3)  ·  Menstruation Disturbances (3)  ·  Metrorrhagia (3)  ·  Adenoviridae Infections (1)  ·  Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Bradycardia (1)  ·  Central Nervous System Infections (1)

Broader conditions

Female Urogenital Diseases (57)  ·  Female Urogenital Diseases and Pregnancy Complications (57)  ·  Genital Diseases (57)  ·  Genital Diseases, Female (57)  ·  Pathologic Processes (57)  ·  Pathological Conditions, Signs and Symptoms (57)  ·  Urogenital Diseases (57)  ·  Uterine Diseases (57)  ·  Uterine Hemorrhage (57)  ·  Hemorrhage (54)  ·  Menstruation Disturbances (54)  ·  Neoplasms (16)  ·  Neoplasms by Histologic Type (16)  ·  Neoplasms, Connective and Soft Tissue (15)  ·  Neoplasms, Muscle Tissue (15)

Interventions

Tranexamic Acid (8)  ·  estradiol, norethindrone drug combination (6)  ·  Estradiol (5)  ·  Norethindrone Acetate (5)  ·  elagolix (4)  ·  relugolix (4)  ·  ferrous sulfate (3)  ·  ulipristal acetate (3)  ·  Iron (2)  ·  Levonorgestrel (2)  ·  Medroxyprogesterone Acetate (2)  ·  linzagolix (2)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)

Sponsors

AbbVie (5)  ·  Assiut University (4)  ·  Ferring Pharmaceuticals (3)  ·  Myovant Sciences GmbH (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Birmingham Women's NHS Foundation Trust (2)  ·  ObsEva SA (2)  ·  Ocon Medical Ltd. (2)  ·  Spark Biomedical, Inc. (2)  ·  All For Women Healthcare, Illinois (1)  ·  Bakirkoy Dr. Sadi Konuk Research and Training Hospital (1)  ·  Bayer (1)  ·  Baylor College of Medicine (1)  ·  Bio Genuine (Shanghai) Biotech Co., Ltd. (1)  ·  Cardioangiologisches Centrum Bethanien (1)

Countries

United States (31)  ·  Canada (5)  ·  Brazil (4)  ·  Poland (4)  ·  Czechia (3)  ·  Hungary (3)  ·  Israel (3)  ·  Netherlands (3)  ·  Puerto Rico (3)  ·  South Africa (3)  ·  United Kingdom (3)  ·  Belgium (2)  ·  Chile (2)  ·  China (2)  ·  Germany (2)

Top investigators

Navid Khodaparast, PhD (2)  ·  ObsEva SA (2)  ·  Allison Wheeler (1)  ·  Almereau Prollius, MD (1)  ·  Amy Brenner, MD (1)  ·  Ashli Lawson, MD (1)  ·  Chi Hornik, PharmD (1)  ·  Christopher C Destephano, MD, MPH (1)  ·  Claude Fortin, MD (1)  ·  Congjian Xu (1)  ·  Dang Q Vinh, MD (1)

Results publications

PMID 31971678, PMID 34878624, PMID 36357960, PMID 37477173, PMID 37863160, PMID 21043553, PMID 33596357, PMID 33650259, PMID 34553161, PMID 34582715, PMID 35415708, PMID 35675604, PMID 36116480, PMID 37183454, PMID 39381651, PMID 39466126, PMID 40326221, PMID 40543832, PMID 12423842, PMID 20859150, PMID 20942615, PMID 21777897, PMID 21867401, PMID 24614374, PMID 24949994, PMID 25588784, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31777949, PMID 31814149, PMID 32324313, PMID 32497307, PMID 32702363, PMID 32835865, PMID 33029806, PMID 33903114, PMID 34218053, PMID 34302290, PMID 35370711

NIH funding

2016 (2), 2017 (1), R21HD091337 (1)